Xconomy National

Archives

by in

Entry	Author	Date	Location
XSITE 2011: The Entrepreneurship Era. The Day in Pictures	Erin Kutz	06/21/11	Boston
NeuroHealing Repurposes Drugs, Resulting in Potential New Remedies For CNS Disorders	Arlene Weintraub	06/02/11	Boston
Agenda Announced for Most Exciting XSITE Yet: We Got 20-Plus Startups, Founders’ Stories, Incubator Debaters, & Provocative Keynoters	Robert Buderi	05/26/11	Boston
David Cancel, Stephen Kaufer, Katie Rae, and Others Join XSITE Program on June 16	Gregory T. Huang	04/28/11	Boston
What do Desh Deshpande, Gilt Groupe, Nobelist Phil Sharp, & Intellectual Ventures Have in Common? All Are Keynoting at XSITE 2011-The Entrepreneurship Era	Robert Buderi	04/20/11	Boston
Biogen Idec Seeks Science-Savvy CEO, LifeImage Partners With EMC, GenomeQuest Aims to be Genetic Google, & More Boston-Area Life Sciences News	Rebecca Zacks	02/26/10	Boston
Six Tips on How to Spot a Winning Biotech, From Dendreon Co-Founder Chris Henney	Luke Timmerman	10/14/09	Seattle
Dendreon May Not Survive Its Success: Q&A with Founder Chris Henney, Part 1	Luke Timmerman	07/27/09	Seattle
Biogen Gets Int’l Rights to Acorda’s MS Drug	Roxanne Palmer	07/01/09	Boston
Biogen Reports 10th PML Case in Tysabri Patient	Roxanne Palmer	06/29/09	Boston
EMD Serono Staging Battle Against Multiple Sclerosis in Boston, Chief Says	Ryan McBride	06/08/09	Boston
Biotech Survival Index: Boston Life Sciences Companies Brace for Long, Hard Winter	Luke Timmerman	11/25/08	Boston
Alnylam–Isis Venture Regulus, Leader in MicroRNA Drugs, Aspires to Create New Paradigm of Treatments	Luke Timmerman	10/24/08	San Diego
Seeding Labs Kickstarts Science in Developing Countries	Erik Mellgren	06/24/08	Boston
Genzyme Seeks Dual Approval, Google Health Picks Another Massachusetts Partner, Biogen Shareholders To Provide Closure (Maybe), & More Life Science News	Rebecca Zacks	06/19/08	Boston
Biogen Directors Win Backing From Third Advisory Firm, Icahn Could Be Heading For Defeat	Luke Timmerman	06/12/08	Boston
Biogen Idec’s Nominees Win Support from Shareholder Advisory Firms	Luke Timmerman	06/10/08	Boston
Icahn Turns Up Heat, Files Suit to Force Biogen Idec to Turn Over Records of Failed Sale	Robert Buderi	04/09/08	Boston
Exact Sciences Puts Itself on the Block After Investor’s Prodding	Rebecca Zacks	03/18/08	Boston
Biogen Bouncing Back From Tysabri Warning News	Rebecca Zacks	02/28/08	Boston
With a Whole Lot of Spending to Do, Vertex Seeks Some $400 Million in Stock and Note Offerings	Rebecca Zacks	02/13/08	Boston
Biogen Idec: Earnings Up, Gauntlet Down, Headhunters All Around?	Rebecca Zacks	02/07/08	Boston
ImmunoGen Scores $1.5M From Biogen Idec	Rebecca Zacks	02/04/08	Boston
Icahn to Nominate Three, Including Two Harvard Bigwigs, to Biogen Idec Board	Rebecca Zacks	01/28/08	Boston
Icahn: Biogen Idec Will Be Bought	Robert Buderi	01/16/08	Boston
Biogen Idec’s Tysabri Approved for Crohn’s	Rebecca Zacks	01/14/08	Boston
Biogen Idec, Vertex, and Genzyme Try Different Ways to Skin the Innovation Cat	Rebecca Zacks	12/19/07	Boston
Biogen Inks $380 Million Deal With Swiss Company	Rebecca Zacks	11/20/07	Boston
Bidding for Biogen Idec Could Begin in Early November, Report Says	Robert Buderi	10/26/07	Boston
Biogen-Icahn? Pfiz-ogen or Pfiz-zyme? Is All of Cambridge Biotech Suddenly Up For Sale?	Robert Buderi	10/24/07	Boston
Page 1 of 2	next page »